Predicting Factors and Risk Stratification for Return Visits to the Emergency Department Within 72 Hours in Pediatric

Sheng-Feng Sung1, Kang Ernest Liu, Solomon Chih-Cheng Chen

  • 1From the *Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City; †Department of Economics, National Chung Cheng University, Chiayi County; ‡Departments of Pediatrics and Medical Research, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City; §Department of Information Management and Institute of Healthcare Information Management, National Chung Cheng University, Chiayi County; and ∥Information Technology Office, Taipei City Hospital, Taipei, Taiwan.

Insights

Younger children visiting the emergency department (ED) on weekdays or during early morning hours on weekends are at higher risk for return visits (RVs). Identifying these pediatric patients can improve emergency care quality.

Area of Science:

  • Pediatric Emergency Medicine
  • Healthcare Quality Improvement
  • Health Services Research

Background:

  • Return visits (RVs) to the emergency department (ED) serve as a critical quality indicator for healthcare facilities.
  • Understanding factors influencing pediatric RVs is essential for enhancing emergency care quality.

Purpose of the Study:

  • To identify pediatric patients at high risk for return visits to the ED.
  • To utilize readily available patient characteristics during an ED visit for risk stratification.

Main Methods:

  • Retrospective analysis of 35,435 pediatric ED visits from an urban hospital network in 2007.
  • Multivariable logistic regression and classification and regression tree techniques were employed to identify risk factors and high-risk groups.

Main Results:

  • A 6.47% rate of RVs within 72 hours was observed among discharged pediatric patients.
  • Factors associated with increased RV probability included younger age, weekday visits, symptom-based diagnoses, and care by a female physician.
  • Children under 6.5 years visiting on weekdays or during specific early morning weekend/holiday hours showed the highest RV risk.

Conclusions:

  • The study identified key factors contributing to pediatric ED return visits.
  • Specific high-risk groups for RVs were identified, suggesting targeted interventions.
  • Further research, including intervention studies, should focus on these identified at-risk pediatric populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
518
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
838
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.3K